Covid new strain: Coronavirus hybrid of Indian and Kent variant is 'very dangerous'

“Vietnam has uncovered a new COVID-19 variant combining characteristics of the two existing variants first found in India and the UK,” Nguyen Thanh Long said. “The new one is… very dangerous.” Laboratory cultures of the new strain showed the virus replicated itself very quickly. Many cases of the new strain have appeared in different parts of Vietnam in a short period of time.

Passengers who arrive into the UK from countries, like Vietnam, that aren’t on the red list do not need to quarantine in a hotel for 10 days.

The World Health Organisation (WHO) renamed the Covid variants using the Greek alphabet.

The new variant system:

• The UK/Kent variant (B.1.1.7) is Alpha.
• The South African variant (B.1.351) is Beta.
• The Brazilian variant (P.1) is Gamma.
• The Indian variant (B.1.617.2) is Delta.

There are also six variants of interest:

1. A US variant (B.1.427/B.1.429) named Epsilon.
2. P.2, found in Brazil, named Zeta.
3. B.1.525, found in multiple countries, named Eta.
4. P3, found in the Philippines, named Theta.
5. B.1.526, found in the US, named Iota.
6. B.1.617.1, found in India, named Kappa.

DON’T MISS

What are antibodies?

LiveScience explained that antibodies are “specialised, Y-shaped proteins that bind like a lock-and-key to the body’s foreign invaders”, such as coronavirus.

Once antibodies bind to their target, such as coronavirus, they “mark it for destruction”.

If the Y144 deletion mutation makes it harder for antibodies to stick to coronavirus, then in essence, it can evade the immune system.

Vaccinations are also key in prompting the immune system in creating antibodies.

However, if the Y144 deletion mutation makes it harder for antibodies to stick to the coronavirus, this strain might affect vaccine efficacy.

In addition to the Y144 deletion mutation, the strain is also feared to be more transmissible.

This is indeed a dangerous mix, a coronavirus strain that is more easily spreading to others and could possibly reduce the effectiveness of vaccines.

The WHO will be looking at the genome profile of the new troublesome variant.